AstraZeneca (United Kingdom) Overview

  • Founded
  • 1998

Founded
  • Status
  • Acquired/​Merged

  • Employees
  • 7,352

Employees
  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

AstraZeneca (United Kingdom) General Information

Description

Provider of antimalarial medication brands. The company consists of three antimalarial brands, Paludrine, Avloclor, Savarine developed by AstraZeneca UK Limited.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • 1 Francis Crick Avenue
  • Cambridge Biomedical Campus
  • Cambridge CB2 0AA
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AstraZeneca (United Kingdom) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AstraZeneca (United Kingdom)‘s full profile, request access.

Request a free trial

AstraZeneca (United Kingdom) Patents

AstraZeneca (United Kingdom) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-1323717-A1 Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl) acetic acid derivatives Inactive 27-Dec-2001 0000000000
JP-2010132690-A Method for producing 2-(6-substituted-1,3-dioxan-4-yl) acetic acid derivative Pending 27-Dec-2001 0000000000
JP-2005519898-A Method for producing 2- (6-substituted-1,3-dioxane-4-yl) acetic acid derivative Pending 27-Dec-2001 0000000000
US-20050090674-A1 Via quaternary phosphonium salt as phase transfer catalyst; oxidation Active 27-Dec-2001 0000000000
US-7718812-B2 Via quaternary phosphonium salt as phase transfer catalyst; oxidation Active 27-Dec-2001 C07D319/06 00
To view AstraZeneca (United Kingdom)’s complete patent history, request access »

AstraZeneca (United Kingdom) Executive Team (1)

Name Title Board Seat Contact Info
Peter Selley President & Chief Executive Officer
To view AstraZeneca (United Kingdom)’s complete executive team members history, request access »

AstraZeneca (United Kingdom) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial